00069-1309 RETACRIT - CanMED: NDC

Product NDC:

00069-1309

Brand Name:

RETACRIT

Generic Name:

epoetin alfa-epbx

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: EPOETIN

Strength: 40000.0

Unit: [iU]/mL

Packages:

Code: 00069-1309-04

Description: 4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)

Effective Date: June 18, 2018

Discontinued:

Code: 00069-1309-10

Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-10) > 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)

Effective Date: June 18, 2018

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Erythropoiesis-Stimulating Agent

Minor Class:

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox